As per a report by Bar & Bench, the Delhi High Court on November 19 refused to entertain ten intellectual property suits for lack of territorial jurisdiction, applying Justice Kaurav's November 3 ruling in ABD Maestro Private Limited v. Great Galleon Ventures Ltd, in which he returned 17 commercial suits. The suits included patent disputes involving Novartis and Waaree Energies and a design suit by Nyra Chocolates. The judge said that even where part of the cause of action arose in Delhi, the court could decline to hear a suit that has a stronger connection to another forum.
In Novartis' patent suit over the cancer drug Dabrafenib, the court accepted that the allegedly infringing version was sold in Delhi but held that Mumbai had a closer link because Novartis' Indian affiliate holding the marketing and import licence is based there. In the suit by the German company Gebr Schmid, the injunction sought would also have stopped manufacture, and the products were made in Surat. In the Nyra suit, a trap order placed with a dealer in Bihar was found to have been delivered to Nyra in Indore once freight was paid by its agent, and the bill carried a Siwan jurisdiction clause. All ten plaints were returned for presentation before the appropriate courts. A larger bench of the High Court reserved its verdict on the same issue less than two weeks earlier.
Comments
0 commentsNo comments yet — be the first.